← Back to Search

Glucosano App + Coaching for Type 1 Diabetes

N/A

Recruiting

Research Sponsored by Sarah MacLeish

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Clinical diagnosis of T1D requiring treatment with insulin at the time of consent

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 4 weeks, 3 months, 6 months, 9 months, 12 months

Awards & highlights

Study Summary

This trial will test if a new program & app can reduce disparities in diabetes tech use among Black/African American children & young adults.

Who is the study for?

This trial is for Black/African American children and young adults with type 1 diabetes who are willing to wear a glucose monitor and consider its continuous use. They must be diagnosed with T1D, treated with insulin, not using an automated insulin delivery system recently, and have English-speaking guardians.Check my eligibility

What is being tested?

The study tests if a new computer program for diabetes teams, along with the Glucosano smartphone app and support from a community health worker can improve the use of diabetes technologies among Black/African American patients.See study design

What are the potential side effects?

Since this trial involves technology assistance rather than medication, traditional side effects are not applicable. However, participants may experience discomfort or skin irritation from wearing the glucose monitor.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have type 1 diabetes and need insulin.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 4 weeks, 3 months, 6 months, 9 months, 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 4 weeks, 3 months, 6 months, 9 months, 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4 weeks, 3 months, 6 months, 9 months, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in percentage of participants who remain on AID as measured by medical record review

Change in percentage of participants who start on automated insulin delivery (AID) as measured by medical records review

Secondary outcome measures

Benefits and Burdens of CGM as measured by Benefits and Burdens of CGM scale

CGM satisfaction as measured by the CGM satisfaction scale

Change in barriers to technology as measured by Barriers to Technology Checklist

+28 more

Trial Design

2Treatment groups

Active Control

Group I: Standard of CareActive Control1 Intervention

Participants in this arm follow standard of care procedures.

Group II: Diabetes Dashboard and Community Health WorkerActive Control2 Interventions

Participants diabetes technology devices will be linked to a remote patient monitoring dashboard and will have access to a Smartphone application, as well as scheduled and as needed visits with a community health worker.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Sarah MacLeishLead Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,359 Previous Clinical Trials

4,314,532 Total Patients Enrolled

KeborMedUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals aged 35 or older eligible for inclusion in this trial?

"In accordance with the trial's inclusion criteria, participants must be aged between 8 and 18 to take part in this research."

Answered by AI

Does my profile meet the criteria to partake in this clinical research?

"Candidates for this medical trial are required to have type 1 diabetes, be between 8 and 18 years old, and will ultimately number 60 participants."

Answered by AI

Are there any vacancies for volunteers in this research endeavor?

"It seems that the clinical trial in question is currently not recruiting patients. According to information found on clinicaltrials.gov, it was first posted on January 2nd 2024 but its last update occurred October 3rd 2023. On a brighter note, 1280 other studies are actively looking for participants as of now."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

GO TEAM: Glucose Optimization Through Technology Assisted Management

Sarah MacLeish 2024. "GO TEAM: Glucose Optimization Through Technology Assisted Management". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06074458.